The Fc and glycoengineered antibodies market offers promising opportunities driven by a robust pipeline, significant interest ...

Fusion Antibodies reported further validation of its OptiMAL discovery platform on Wednesday, saying its collaboration with ...

Chronic kidney disease is a growing health concern affecting about 1 in 10 Swedes. The condition involves a gradual decline ...

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in ...

Scientists at the Jackson Laboratory (JAX) have developed an antibody-based therapy against influenza A virus (IAV), which they suggest could change the way the world fights flu, one of the deadliest ...

HERSHEY, Pa. — The body has an intricate system to defend against infections where each type of immune cell plays a distinct role. Now, a study led by researchers from the Penn State College of ...

Dementia is a condition that results in progressive memory or thinking problems. It's now the most common cause of death in ...

Active LN and the presence of U1-RNP antibodies were linked to low BMD and osteoporosis among patients with SLE.

The decision to stop the Phase IIb study was driven by “strategic business reasons,” according to a federal clinical trials ...

September 15, 2025ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.06496 EPS, expectations ...